The disparity in prostate cancer‐specific mortality for Black men with ESKD for advanced stages was eliminated after adjustment for PSA and Gleason score in the advanced prostate cancer stages, which may indicate that the aggressive nature of prostate cancer at presentation, which could be due to delayed diagnosis, was driving it. This evidence concerns the gene KLK3 and Familial prostate cancer.